ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 770,95
0,48%
Dow Jones
43 908,22
0,97%
DAX
21 042,00
0,18%
Brent Oil
78,715
-0,64%
Bitcoin
104 995,34
2,91%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Polemos (PLMO) Cours

Polemos

Polemos (PLMO)

LSE
0,70
0,00
(0,00%)
Fermé 21 Janvier 5:30PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
0,70
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
0,00
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
0,70
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

PLMO Dernières nouvelles

Plus de nouvelles

Pulmo BioTech Inc. Announces that Its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) Shows Early Indications of B

NEW YORK, Nov. 11 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO.OB; Frankfort Borse: PBO) has announced that early experimental results have indicated that its...

11 Novembre 2009
PR Newswire (US)

Pulmo BioTech Inc. Announces Cash Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascular

NEW YORK, Oct. 23 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO; Frankfort Borse: PBO) has announced that it will ultimately receive at least $3.3 million pursuant to...

23 Octobre 2009
PR Newswire (US)

Pulmo BioTech Inc. Announces Further Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascul

NEW YORK, Oct. 21 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO; Frankfort Borse: PBO) has announced has announced further details of its non-binding letter of intent...

21 Octobre 2009
PR Newswire (US)

Pulmo BioTech Inc. Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate

NEW YORK, Oct. 20 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO; Frankfort Borse: PBO) has announced that it has entered into a non-binding letter of intent with...

20 Octobre 2009
PR Newswire (US)

Pulmo BioTech Inc. Announces Paper to be Presented at Symposium

NEW YORK, May 4 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO; Frankfort Borse: PLO) has announced that Dr. Jocelyn Dupuis, the Chief Scientific Officer of its Pulmo...

04 Mai 2009
PR Newswire (US)

Pulmo BioTech Inc. Announces Appointment of Professor John Wallwork as Chairman

NEW YORK, March 17 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO) is pleased to announce the appointment of Professor John Wallwork to the Board of the company as...

17 Mars 2009
PR Newswire (US)

Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse

NEW YORK, Jan. 12 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. has completed a dual listing. The Company's shares are now listed on the Frankfurt Borse (symbol PBO) in addition to the OTC BB...

12 Janvier 2009
PR Newswire (US)

Pulmo BioTech Inc. Completes Bio-Distribution Studies

NEW YORK, July 7 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC Bulletin Board: PLMO.OB) has announced that its subsidiary, PulmoScience Inc. has completed the bio-distribution studies on its...

07 Juillet 2008
PR Newswire (US)

Pulmo BioTech Announces an Increase in its Stake in PulmoScience

NEW YORK, May 9 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC:PLMO) (BULLETIN BOARD: PLMO) announced today that it has increased its stake in PulmoScience Inc. by 10%, taking its total...

09 Mai 2008
PR Newswire (US)

Pulmo BioTech Announces Appointment of Chief Financial Officer

NEW YORK, May 2 /PRNewswire-FirstCall/ -- Pulmo BioTech Inc. (OTC:PLMO) (BULLETIN BOARD: PLMO) announced today that it has appointed Rajiv Garg as it Chief Financial Officer. Pulmo BioTech...

02 Mai 2008
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

PLMO - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is 0,70p
What is the 1 year trading range for share price?
has traded in the range of 0,00p to 0,00p during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NTOGNostra Terra Oil And Gas Company Plc
0,043p
(36,51%)
522,02M
BSFABsf Enterprise Plc
3,375p
(35,00%)
13,75M
STBSecure Trust Bank Plc
465,00p
(33,62%)
824,55k
TIATialis Essential It Plc
26,50p
(23,26%)
105,62k
CBGClose Brothers Group Plc
298,40p
(21,90%)
4,6M
NTQEnteq Technologies Plc
1,25p
(-23,31%)
3,22M
BANKFiinu Plc
8,625p
(-15,85%)
19,8M
TIRTiger Royalties And Investments Plc
0,135p
(-15,63%)
75,44M
RCGHRc365 Holding Plc
1,80p
(-14,29%)
1,7M
INDIIndus Gas Limited
7,80p
(-13,33%)
214,66k
NTVONativo Resources Plc
0,0021p
(0,00%)
2,71B
PREMPremier African Minerals Limited
0,026p
(-3,70%)
623,1M
NTOGNostra Terra Oil And Gas Company Plc
0,043p
(36,51%)
522,02M
TRPTower Resources Plc
0,0305p
(0,00%)
504,66M
SYMESupply@me Capital Plc
0,003p
(-3,23%)
469,16M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
PLMO
BIT
S25058
SG ISSUER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés